Rigel Pharmaceuticals (RIGL) EBT Margin Growth (5y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,112.00 |
| Dec 31, 2025 | 13,681.00 |
| Sep 30, 2025 | 11,684.00 |
| Jun 30, 2025 | 16,869.00 |
| Mar 31, 2025 | -1,651.00 |
| Dec 31, 2024 | 19,647.00 |
| Sep 30, 2024 | 23,801.00 |
| Jun 30, 2024 | 29,208.00 |
| Mar 31, 2024 | 16,255.00 |
| Dec 31, 2023 | 75,768.00 |
| Sep 30, 2023 | 46,828.00 |
| Jun 30, 2023 | 140,561.00 |
| Dec 31, 2022 | -59,241.00 |
| Sep 30, 2022 | 187,727.00 |
| Mar 31, 2022 | 28,371.00 |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 50,395.00 |
| Jun 30, 2021 | 10,116.00 |
| Mar 31, 2021 | 39,821.00 |
| Dec 31, 2020 | 10,252.00 |